GlucoTrack Inc
Research GlucoTrack Inc (GCTK) on Bullrun: market cap USD 858.26K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGCTK
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 858.26K
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 16.89M
- Free cash flow-USD 16.44M
Valuation Snapshot
latest market cap is USD 858.26K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 19.39M | -USD 15.34M | n/a | 31.22 | USD 7.38M | USD 3.45M | USD 2.83M |
| FY2024 | USD 0 | -USD 22.60M | -USD 12.59M | n/a | 4106 | USD 5.62M | USD 267.00K | -USD 13.00M |
| FY2023 | n/a | -USD 7.10M | n/a | n/a | 34.18 | USD 4.49M | USD 196.00K | USD 3.20M |
| FY2022 | n/a | -USD 4.44M | -USD 3.73M | n/a | 0.29 | USD 2.31M | USD 192.00K | USD 1.23M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 858.26K | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 3.52M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.91M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 5.50M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 22.00M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 65.05M | n/a | n/a | n/a |
About GlucoTrack Inc
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GlucoTrack Inc's market cap?
GlucoTrack Inc's market capitalization is USD 858.26K.
What does GlucoTrack Inc do?
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.